Literature DB >> 23103312

Interaction profile of Zizyphus jujuba with phenytoin, phenobarbitone, and carbamazepine in maximal electroshock-induced seizures in rats.

Monika Pahuja1, Thomas Kleekal, K H Reeta, Manjari Tripathi, Yogendra Kumar Gupta.   

Abstract

The antiepileptic effect of hydroalcoholic extract of Zizyphus jujuba (HEZJ) in experimental seizures was demonstrated earlier. The present study aimed to evaluate the pharmacokinetic and pharmacodynamic interactions of HEZJ with phenytoin (PHT), phenobarbitone (PB), and carbamazepine (CBZ) in maximal electroshock (MES)-induced seizures in male Wistar rats. Maximal electroshock (70 mA, 9 ms pulse width, 0.2 s) was used to induce seizures. Blood samples were collected at two time points for estimation of serum PHT, PB, and CBZ levels using high-pressure liquid chromatography (HPLC). Co-administration of HEZJ with the sub-therapeutic doses of PHT, PB, and CBZ exhibited 66.7, 66.7, and 50.0% protection against tonic hind limb extension as compared to 33.3, 33.3, and 50% protection respectively, in the groups treated with PHT, PB, and CBZ alone in their sub-therapeutic doses. Co-administration of HEZJ with the sub-therapeutic doses of these antiepileptic drugs (AEDs) showed significant improvement in cognitive functions as compared to MES group as well as these AEDs alone. A significant increase in glutathione levels and decrease in malondialdehyde levels were observed with pretreatment of HEZJ with the sub-therapeutic doses of these AEDs. Co-administration of HEZJ with PHT, PB, and CBZ did not cause any significant changes in the serum concentrations of these AEDs. The results of the present study indicate that the co-administration of HEZJ with sub-therapeutic doses of PHT and PB potentiated the antiepileptic effect of PHT and PB in MES-induced seizures with no change found in the antiepileptic effect of CBZ.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103312     DOI: 10.1016/j.yebeh.2012.08.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

Review 1.  Awareness and current knowledge of epilepsy.

Authors:  Asmat Ullah Khan; Muhammad Akram; Muhammad Daniyal; Naheed Akhter; Muhammad Riaz; Naheed Akhtar; Mohammad Ali Shariati; Fozia Anjum; Samreen Gul Khan; Abida Parveen; Saeed Ahmad
Journal:  Metab Brain Dis       Date:  2019-10-11       Impact factor: 3.584

2.  Adjuvant role of Ocimum sanctum hydroalcoholic extract with carbamazepine and phenytoin in experimental model of acute seizures.

Authors:  Sudhir Chandra Sarangi; Soumya Sucharita Pattnaik; Dipesh Joshi; P Prarthana Chandra; Thomas Kaleekal
Journal:  Saudi Pharm J       Date:  2020-09-21       Impact factor: 4.330

3.  Quantitative and pattern recognition analyses of magnoflorine, spinosin, 6'''-feruloyl spinosin and jujuboside A by HPLC in Zizyphi Semen.

Authors:  Won Il Kim; Bing Tian Zhao; Hai Yan Zhang; Je Hyun Lee; Jong Keun Son; Mi Hee Woo
Journal:  Arch Pharm Res       Date:  2013-12-06       Impact factor: 4.946

Review 4.  The effects of herbal medicine on epilepsy.

Authors:  Wei Liu; Tongtong Ge; Zhenxiang Pan; Yashu Leng; Jiayin Lv; Bingjin Li
Journal:  Oncotarget       Date:  2017-07-18

5.  Insights about multi-targeting and synergistic neuromodulators in Ayurvedic herbs against epilepsy: integrated computational studies on drug-target and protein-protein interaction networks.

Authors:  Neha Choudhary; Vikram Singh
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

Review 6.  Chinese Herbal Medicine for Treating Epilepsy.

Authors:  Chia-Hui Lin; Ching-Liang Hsieh
Journal:  Front Neurosci       Date:  2021-07-02       Impact factor: 4.677

7.  Evaluation of anticonvulsant actions of dibromophenyl enaminones using in vitro and in vivo seizure models.

Authors:  Mohamed G Qaddoumi; Kethireddy V V Ananthalakshmi; Oludotun A Phillips; Ivan O Edafiogho; Samuel B Kombian
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.